Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Duloxetine in panic disorder with somatic gastric pain.

Preve M, Nisita C, Bellini M, Dell'osso L.

Neuropsychiatr Dis Treat. 2013;9:1811-3. doi: 10.2147/NDT.S35922. Epub 2013 Nov 21.

2.

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Foster RH, Goa KL.

CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.

PMID:
23338224
3.

[Panic attacks simulate presence of somatic illnesses].

Latas M, Soldatović I, Stamenović M, Starcević V.

Med Pregl. 2009 Mar-Apr;62(3-4):165-70. Review. Serbian.

PMID:
19623848
4.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
5.

Open-label support for duloxetine for the treatment of panic disorder.

Simon NM, Kaufman RE, Hoge EA, Worthington JJ, Herlands NN, Owens ME, Pollack MH.

CNS Neurosci Ther. 2009 Winter;15(1):19-23. doi: 10.1111/j.1755-5949.2008.00076.x.

PMID:
19228176
6.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
7.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
8.

[Rethink the panic disorder].

Amami O, Aloulou J, Siala M, Aribi L.

Encephale. 2010 Apr;36(2):100-4. doi: 10.1016/j.encep.2009.02.007. Epub 2009 Sep 11. Review. French.

PMID:
20434625
9.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
10.

The role of duloxetine in the treatment of anxiety disorders.

De Berardis D, Serroni N, Carano A, Scali M, Valchera A, Campanella D, D'Albenzio A, Di Giuseppe B, Moschetta FS, Salerno RM, Ferro FM.

Neuropsychiatr Dis Treat. 2008 Oct;4(5):929-35.

11.

A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.

Clin Neuropharmacol. 2007 Nov-Dec;30(6):326-34.

PMID:
18090457
12.

Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.

Versiani M, Cassano G, Perugi G, Benedetti A, Mastalli L, Nardi A, Savino M.

J Clin Psychiatry. 2002 Jan;63(1):31-7.

PMID:
11838623
13.

Diagnosis and management of panic disorder in older patients.

Flint AJ, Gagnon N.

Drugs Aging. 2003;20(12):881-91. Review.

PMID:
14565781
14.
15.

Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.

Van Apeldoorn FJ, Van Hout WJ, Timmerman ME, Mersch PP, den Boer JA.

J Affect Disord. 2013 Sep 5;150(2):313-9. doi: 10.1016/j.jad.2013.04.012. Epub 2013 May 12.

PMID:
23676529
16.

A risk-benefit assessment of pharmacological treatments for panic disorder.

Bennett JA, Moioffer M, Stanton SP, Dwight M, Keck PE Jr.

Drug Saf. 1998 Jun;18(6):419-30.

PMID:
9638387
17.

Facing the fear--clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia.

Liebscher C, Wittmann A, Gechter J, Schlagenhauf F, Lueken U, Plag J, Straube B, Pfleiderer B, Fehm L, Gerlach AL, Kircher T, Fydrich T, Deckert J, Wittchen HU, Heinz A, Arolt V, Ströhle A.

Eur Neuropsychopharmacol. 2016 Mar;26(3):431-44. doi: 10.1016/j.euroneuro.2016.01.004. Epub 2016 Jan 22.

PMID:
26837851
18.

[Panic disorder and panic attack].

Abbar M.

Encephale. 1996 Dec;22 Spec No 5:13-8. Review. French.

PMID:
9138941
19.

Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G.

Cochrane Database Syst Rev. 2016 Apr 13;4:CD011004. doi: 10.1002/14651858.CD011004.pub2. Review.

20.

Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.

Humble M, Wistedt B.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:21-39. Review.

PMID:
1431019

Supplemental Content

Support Center